• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Omar Ford

Articles by Omar Ford

MDD's Diagnostics Extra

Dec. 12, 2014
By Omar Ford

Transcatheter Tech expands Trinity to include transfemoral procedures

Dec. 12, 2014
By Omar Ford
Transcatheter Technologies (Regensburg, Germany), a private company, that has developed a third-generation transapical transcatheter aortic valve implantation (TAVI) system called Trinity, said that it has expanded that technology platform to include a transfemoral version as well.
Read More

Cytori sees STAR rising with IDE evaluating cell therapy technology

Dec. 11, 2014
By Omar Ford

bioTheranostics BCI test shows strong predictive power according to studies

Dec. 10, 2014
By Omar Ford

Edwards hoping for early 2016 approval of Sapien 3 Transcatheter Heart Valve

Dec. 9, 2014
By Omar Ford
An FDA approval for Edwards Lifesciences' (Irvine, California) Sapien 3 Transcatheter Heart Valve could come in early 2016, the company said in an investor's call on Monday. Original expectations for FDA approval were estimated for mid-2016.
Read More

Corvida Medical focuses on reducing healthcare workers exposure to chemo

Dec. 8, 2014
By Omar Ford

MDD's Diagnostics Extra

Dec. 5, 2014
By Omar Ford

Pivotal med-tech industry issues for 2015 are outlined in new PwC report

Dec. 5, 2014
By Omar Ford
In its annual top health industry issues of 2015 report, PricewaterHouseCoopers (PwC; New York) PwC's Health Research Institute (HRI) said it anticipates that the $2.8 trillion U.S. healthcare sector will start feeling like a true market. HRI's report explores several trends that are expected to shape the sector in 2015, including the expansion of do-it-yourself healthcare, how industry will adapt to the newly insured, and consumers' competing desires for convenience and privacy. Top health industry issues of 2015 include insights from a survey of 1,000 U.S. consumers and interviews with health industry leaders.
Read More

Google faces potential challenges, roadblocks in getting Glass adopted

Dec. 1, 2014
By Omar Ford
When Jay Zuerndorfer, a student researcher at the Georgia Institute of Technology (Atlanta) received the opportunity to develop an application for Google Glass it was like a dream come true. Zuerndorfer and a research team from Georgia Tech were able to create speech-to-text software for Google Glass that helps hard-of-hearing users with everyday conversations. A hard-of-hearing person wears Glass while a second person speaks directly into a smart phone.
Read More

Through the Looking Glass: part 2 of 3: Big and small players flock to develop apps for Google Glass

Nov. 26, 2014
By Omar Ford
In October 2013, Royal Philips (Amsterdam, the Netherlands) in partnership with Accenture (Dublin, Ireland) revealed a proof-of-concept demonstration that uses a Google Glass head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. In doing so, Philips became a pioneer of sorts.
Read More
Previous 1 2 … 70 71 72 73 74 75 76 77 78 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 28, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 28, 2025.
  • Boston Scientific Acurate Prime Aortic Valve System

    In TAVR setback, Boston Sci pulls plug on Acurate valves

    BioWorld MedTech
    Boston Scientific Corp. reported the latest setback in its transcatheter aortic valve replacement (TAVR) aspirations with the news that it is officially...
  • 3d rendering of bispecific antibodies

    Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody

    BioWorld
    Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe